Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • TF_Legit.Health_Plus
  • Licenses and accreditations
  • External documentation
    • 01 ES 🇪🇸 regulations
    • 02 US 🇺🇸 CFR FDA
    • 03_Clinical studies
    • 04 EU 🇪🇺 Medical devices
      • 04_01_2007_MDD 93_42_EEC
      • 04_02_2017_745-MDR_20200424_EN
      • 04_03_2017_2185 MD coding
      • 04_04_2023_607_MDR & IVDR transition approval
      • 04_05_2012_207_en_Electronic IFU
      • 04_06_2021_2226_en_Electronic IFU
      • Guides
        • 04_G01_MD_borderline_manual_05_2019_en_0
        • 04_G02_MD_borderline_manual_12-2022_en
        • 04_G03_MedDev 2 12-1_rev8_en_Vigilance system
        • 04_G04_MDCG_2020_5_guidance_clinical_evaluation_equivalence_en_0
        • 04_G05_MDCG_2020_7_guidance_pmcf_plan_template_en_0
        • 04_G06_MDCG_2020_8_guidance_pmcf_evaluation_report_en_0
        • 04_G07_MDCG 2020-1 Clinical Evaluation MDSW
        • 04_G08_MDCG 2022-4 Rev.1 Transitional Provisions_changes
        • 04_G09_MDCG_2022-21_en_PSUR
        • 04_G10_MDCG_Q&A Vigilance_2023-3_en_0
        • 04_G11_MEDDEV_2_1_6_072016_en
        • 04_G12_MedDev_2_7_1_rev4_en Clinical Evaluation
        • 04_G13_2023 C 163 06_Summary of the CIR
        • 04_G14_MDGC_Transitional provision under article 120_2020-3_en
        • 04_G15_Manual on borderline and classification for medical devices
        • 04_G16_Principles and Practices for Medical Device Cybersecurity
        • 04_G17_IMDRF Machine learning enabled Medical devices:Key terms and definitions
    • 05_GP-004 Vigilance system
    • 06_Machine learning
    • 07 Quality regulations
    • 08 MX 🇲🇽 regulations
    • 09 Pharmacy
    • 10 Other
    • 11 UK 🇬🇧 Medical devices
    • 12 EU 🇪🇺 AI Act
  • External documentation
  • 04 EU 🇪🇺 Medical devices
  • Guides

Guides

📄️ 04_G01_MD_borderline_manual_05_2019_en_0

📄️ 04_G02_MD_borderline_manual_12-2022_en

📄️ 04_G03_MedDev 2 12-1_rev8_en_Vigilance system

📄️ 04_G04_MDCG_2020_5_guidance_clinical_evaluation_equivalence_en_0

📄️ 04_G05_MDCG_2020_7_guidance_pmcf_plan_template_en_0

📄️ 04_G06_MDCG_2020_8_guidance_pmcf_evaluation_report_en_0

📄️ 04_G07_MDCG 2020-1 Clinical Evaluation MDSW

📄️ 04_G08_MDCG 2022-4 Rev.1 Transitional Provisions_changes

📄️ 04_G09_MDCG_2022-21_en_PSUR

📄️ 04_G10_MDCG_Q&A Vigilance_2023-3_en_0

📄️ 04_G11_MEDDEV_2_1_6_072016_en

📄️ 04_G12_MedDev_2_7_1_rev4_en Clinical Evaluation

📄️ 04_G13_2023 C 163 06_Summary of the CIR

📄️ 04_G14_MDGC_Transitional provision under article 120_2020-3_en

📄️ 04_G15_Manual on borderline and classification for medical devices

📄️ 04_G16_Principles and Practices for Medical Device Cybersecurity

📄️ 04_G17_IMDRF Machine learning enabled Medical devices:Key terms and definitions

Previous
04_06_2021_2226_en_Electronic IFU
Next
04_G01_MD_borderline_manual_05_2019_en_0
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)